Lv3
278 积分 2023-03-09 加入
The hinge region in androgen receptor control
2天前
已完结
Next generation dual GLP-1/GIP, GLP-1/glucagon, and triple GLP-1/GIP/glucagon agonists: a literature review
7天前
已完结
The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide
21天前
已完结
Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents
21天前
已完结
New insights into the regulation of GIPR signalling
22天前
已完结
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
22天前
已完结
Unravelling the GIPR agonist versus antagonist paradox
22天前
已完结
The effects of anti‐obesity medications on bone metabolism: A critical appraisal
23天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
23天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
23天前
已完结
皖公网安备34019202002308
